CARR vs VERA · P/E 43, rev $21.75B vs $2.51B cap
Carrier Global Corp (CARR) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
VERA does not have a complete income-statement cache yet.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. VERA currently screens at market cap $2.51B.
Not investment advice. Open the CARR and VERA stock pages for the full models.
Not investment advice.